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Sunday, February 21, 2010 119aof G601S-hERG. After nocodazole treatment the G601S-hERG immunostain-
ing pattern changed from perinuclear to one that consisted of focal aggregates
located throughout the cytosol. Nocodazole treatment also increased the
glycolytic processing of G601S-hERG similar to that of wild-type hERG. In
contrast, nocodazole treatment did not alter the immunostaining or glycolytic
processing of R752W-hERG. These data suggest that the tdLQT2 phenotype
for G601S-hERG but not R752W-hERG is regulated by microtubule function.
We conclude that microtubule dependent and independent mechanisms may
regulate the tdLQT2 phenotype.
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Mink Dictates the Alpha Subunit Composition of Surface-Expressed
N-Type Potassium Channels
Vikram A. Kanda, Anthony Lewis, Xianghua Xu, Zoe A. McCrossan,
Geoffrey W. Abbott.
Weill Medical College of Cornell University, New York, NY, USA.
Homomeric and heteromeric complexes formed by members of the Kv3 sub-
family of voltage-gated potassium (Kv) channel alpha subunits generate cur-
rents essential for the high-frequency firing of mammalian neurons. Kv3.1
and Kv3.2 alpha subunits generate delayed rectifier currents, whereas Kv3.4
generates fast-inactivating currents. This ‘N-type’ fast-inactivation occurs via
an N-terminal ‘ball’ domain, which blocks the channel pore directly after open-
ing, preventing Kþ ion flux. Heteromeric channels containing Kv3.4 with either
Kv3.1 or Kv3.2 exhibit N-type inactivation with a rate dependent upon the
number of Kv3.4 alpha subunits in the tetramer. As Kv channel inactivation
and inactivation recovery rates are important determinants of excitable cell ac-
tion potential morphology and refractory period duration, the stoichiometry of
these heteromeric complexes is expected to be tightly regulated. Here, using
channel subunits cloned from rat and transiently expressed in CHO cells, we
show that Kv3.4 current is significantly suppressed (>90%) by the ancillary
beta subunit MinK (KCNE1) and that the suppression can be rescued by co-
expression of Kv3.1. Through use of dominant-negative pore mutants and
N-terminal A and B box (NAB) intra-subfamily binding domain mutants, we
demonstrate that MinK ensures that Kv3.4 alpha subunits can only reach the
surface as part of a heteromeric complex with Kv3.1. Thus, by acting as
a molecular matchmaker, MinK governs Kv channel inactivation rate and,
potentially, cellular excitability and refractory periods.
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Pharmacological-Induced Increase in the Functional Expression Of hERG
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Christie M. McBride, Jennifer L. Smith, Brian P. Delisle.
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The human Ether-a-go-go Related Gene (hERG) Kþ channel is linked to type 2
Long QT Syndrome (LQT2), and most LQT2mutations decrease hERG current
(IhERG). Since LQT2 follows an autosomal dominant inheritance pattern,
increasing the functional expression of WT-hERGmay have therapeutic poten-
tial. The goal of this study was to identify ways to increase IhERG without alter-
ing gating. We tested the hypothesis that nocodazole (noc), an antimicrotubule
agent, and cytochalasin D (cytoD), an antimicrofilament agent, would increase
IhERG because they can alter the kinetics of protein trafficking to and from the
membrane. We cultured HEK293 cells stably expressing WT-hERG in noc
(20˛1/4M) or cytoD (5˛1/4M) for 18-22 hours and measured IhERG using
the whole-cell patch clamp technique. Using a holding potential of 80 mV,
cells were pre-pulsed to 50 mV in 10 mV increments for 5 seconds, followed
by a test-pulse to50 mV for 5 seconds for control, noc, or cytoD treated cells.
The peak IhERG measured during test-pulse was plotted as a function of the pre-
pulse. The data were described using a Boltzmann equation to calculate the
maximal current density (IMAX), midpoint potential for activation (V1/2), and
the slope factor (k) for IhERG activation. Noc treatment did not alter any of these
parameters. CytoD treatment increased IMAX (control=9358 pA/pF, n=5; cy-
toD=156515 pA/pF, n=7) but did not alter not V1/2 or k. CytoD also did not
alter the voltage-dependent rates of IhERG deactivation (n=6, per group). These
data suggest that the functional expression of WT-hERG is increased by inhi-
bition of microfilaments but not microtubules. We conclude that targeting mi-
crofilaments and/or microfilament-dependent proteins may represent a novel
strategy for increasing the functional expression of WT-hERG without altering
IhERG function.
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hERGHeteromeric 1A/1B and Homomeric 1A Channels Exhibit Differen-
tial Pharmacological Sensitivities
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2University of Wisconsin-Madison, Madison, WI, USA.The majority of hERG screens aiming to minimize the risk of drug-induced
long QT syndrome have been conducted using heterologous systems express-
ing the hERG 1a subunit, yet both hERG 1a and 1b subunits contribute to the
channels producing the repolarizing current IKr. Previous studies show that
differences in gating in heteromeric 1a/1b vs. homomeric 1a channels mark-
edly increase repolarizing current during the ventricular action potential and
protect against QT prolongation in computational models. We conducted
a pharmacological analysis of 50 compounds targeting hERG channels and se-
lected for their chemical diversity to evaluate differences in sensitivity that
may influence safety margins or contribute to a stratified risk analysis. Exper-
iments were carried out using the IonWorksTM plate-based electrophysiology
device. Non-cumulative, 8-point concentration effect curves were generated,
with each point representing data from 20 to 30 cells. Potency was determined
as IC50 values (˛1/4M) obtained from data normalized to vehicle and 100%
blocking levels and fitted to the Hill equation. To minimize possible sources
of variability, compound potency was assessed using test plates arranged in
alternating columns of 1a and 1a/1b cells. Although most compounds had sim-
ilar potencies at both variants, some surprising differences were observed. For
example, fluoxetine (Prozac) was 6-fold more potent at blocking hERG 1a/1b
compared to 1a channels. The results were robust when compounds were
tested against the hERG 1a and 1a/1b cell lines in parallel, but statistical anal-
ysis encompassing longitudinal variation indicates such differences may not
be sufficient to warrant routine use of hERG 1a/1b in preclinical high through-
put screens. However, our findings have uncovered several important candi-
dates for further risk evaluation as we learn more about native subunit com-
position in different populations or changes in subunit composition during
development.
624-Pos
A New Mechanism for Long QT Syndrome: Polypeptides Encoded by
hERG1a Non-Sense Mutations Regulate hERG1a/1b Channels
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hERG potassium channels are critical for cardiac action potential repolariza-
tion. Disruption of channel function by inherited mutations in the gene encod-
ing hERG have been shown to cause type 2 long QT syndrome (LQT2) by
perturbing trafficking, assembly, selectivity and activation gating. To date,
most mutations have been studied in heterologous systems expressing the
hERG 1a subunit, yet both hERG 1a and 1b subunits contribute to the channels
producing the repolarizing current IKr. hERG 1a and 1b subunits are structur-
ally identical except for the N terminal region, which is unique and much
shorter in the 1b subunit. Differences in gating result in markedly increased
repolarizing current in heteromeric 1a/1b vs. homomeric 1a channels during
the ventricular action potential and protect against QT prolongation in compu-
tational models. We examined nonsense mutations giving rise to truncations
at different points in the amino terminus of hERG 1a. Surprisingly, these
fragments had little or no effect on maturation of hERG 1a and 1b subunits
expressed in HEK-293 cells. Instead, they altered gating and increased rectifi-
cation as if the channels were homomers of hERG 1a subunits. Thus, by ‘‘com-
plementing’’ the hERG 1b subunit (and its short N terminus), the mutant 1a
fragments reduce the repolarization capability of the channel and mediate
a novel mechanism of type 2 long QT syndrome.
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The Human Ether-a´-go-go Related Gene (hERG) encodes a voltage-activated
Kþ channel. hERG contributes to repolarization of the ventricular action po-
tential as the primary component of the cardiac delayed rectifier Kþ current
(IKr) and has also been shown to modulate neuronal firing frequency. hERG
gating is characterized by rapid inactivation upon depolarization and rapid re-
covery from inactivation and slow closing (deactivation) upon repolarization.
These factors combine to create a resurgent hERG current, where the amplitude
of the current is paradoxically larger with repolarization than with depolariza-
tion. These gating transitions also determine the timing and amplitude of the
resurgent current. Previous data has suggested that the hERG N-terminus reg-
ulates gating kinetics, however the molecular mechanisms are not fully under-
stood. Deletion of the N-terminus (amino acids 2-354) has been shown to speed
channel deactivation and recovery from inactivation compared to that of wild-
type hERG. Relative outward current amplitude is also increased during the de-
polarization phase of N-truncated channels, leading to reduced current
120a Sunday, February 21, 2010rectification. A genetically encoded Eag domain fragment (amino acids 1-135)
was shown to restore slow deactivation to N-truncated channels. Our present
study sought to further investigate Eag domain contributions to hERG gating
kinetics. We coexpressed the genetically encoded Eag domain fragment (N1-
135) with hERG channels bearing a deletion of the N-terminus in Xenopus oo-
cytes and measured current with two-electrode voltage-clamp recordings. Here
we report that coexpression with the N1-135 peptide led to a reduction in rel-
ative outward current and slowed recovery from inactivation resulting in chan-
nels with properties similar to those measured in wild-type hERG. Through reg-
ulation of deactivation and inactivation gating, the Eag domain determines the
physiologically critical resurgent component of hERG current via a non-cova-
lent interaction with the channel.
626-Pos
Mutations Within the S4-S5 Linker Alter Voltage Sensor Constraints Dur-
ing Activation and Deactivation of Herg Kþ Channels
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hERG channel gating is associated with relatively slow voltage sensor move-
ment that limits the rate of channel opening and closing. The mechanistic basis
underlying the constraints upon sensor movement in these channels is unclear.
Here, we have used voltage clamp fluorimetry (VCF) to study the effects of mu-
tations within the S4-S5 linker on voltage sensor movement and its coupling to
the pore. Mutations at G546 had two separable effects on activation and deac-
tivation gating. Substitution of G546 with residues possessing different phys-
ico-chemical properties all (with the exception of G546C) shifted activation
gating by ~30mV in the hyperpolarizing direction. With the activation shift
taken into account, the time constant of ionic current activation was also accel-
erated. In addition, a number of G546 mutants affected deactivation gating, al-
though the effects of different mutations varied. In the most dramatic case, the
G546V mutation induced biphasic deactivation with a pronounced slow com-
ponent that was voltage-independent. Deletion of the N-terminus accelerated
the fast component, but the slow component remained pronounced, suggesting
that the slow component was not mediated by altered interaction with the
N-terminus. VCF measurements of voltage sensor movement in G546V chan-
nels revealed fast and slow components of fluorescence change associated with
deactivation, suggesting that the slow component of ionic current deactivation
is due to slow voltage sensor return that is uncoupled from charge movement.
Taken together, these data suggest: 1) reduced flexibility of the S4-S5 linker
helix reduces constraints on voltage sensor movement during activation gating;
2) normal hERG channel closing involves at least two reconfigurations of the
voltage sensor that are rate-limiting for pore closure.
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The human ether-a-go-go-related gene 1 (hERG1) encodes a voltage-depen-
dent potassium (Kþ) channel which underlies the cardiac delayed-rectifier
Kþ current (IKr). The closing rate of the channel is a major determinant
of the amplitude of outward current, and is regulated by an N-terminal
Per-Arnt-Sim (PAS) domain. Loss of function mutations in hERG1 result
in a loss of IKr and lead to congenital Long QT Syndrome 2 (LQT2).
Only a small percentage of the PAS domain LQT2 mutations have been
characterized in mammalian cells, and these exhibited a variety of defects.
Therefore, it remains unclear as to how LQT2 mutations located in the
PAS domain disrupt hERG1 function. To address this, we have selected
12 PAS domain LQT2 mutations and, using biochemistry and electrophysi-
ology, examined their functional properties when expressed at physiological
temperatures. Our data demonstrate that channels with LQT2 mutations lo-
cated in the PAS domain exhibit a spectrum of deficiencies when cultured
at 37oC. Western blot analysis indicated that some mutations are traffick-
ing-deficient, evident by detection of only the immature form of the channel;
others were indistinguishable from WT hERG1, with enriched expression of
both the immature and mature forms; while the remaining exhibited interme-
diate levels of maturation. Whole-cell patch-clamp analysis revealed that the
LQT2 PAS domain mutants produce functional channels at the cell surface
with perturbed deactivation kinetics. Co-expression of a genetically-encoded
N-terminal peptide with these gating-deficient mutants rescued the gating-
deficiency and fully restored the WT phenotype. Taken together, these
data are the first to characterize purely gating-deficient hERG1 PAS domain
LQT2 mutations expressed in mammalian cells, and show that a genetically-encoded N-terminal peptide is able to fully restore the WT phenotype to the
channels.
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Block of Herg by Trapped Drugs Shows a Different Dependency on Extra-
cellular Potassium Compared to Block of Herg by Drugs That are Not
Trapped
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Block of the cardiac potassium channel HERG by a number of drugs has
been shown to decrease with an increase in the extracellular potassium con-
centration. This dependency on extracellular potassium can be explained by
at least two mechanisms: 1) destabilization of the drug by the permeant ion
2) differential binding to the inactivated state. We have previously shown
that block of HERG by quinidine, a drug that is not trapped after channel de-
activation, correlates better with the permeant ion than with inactivation, in-
dicating that quinidine block is destabilized by the permeant ion.1 We show
here that block of HERG by terfenadine and bepridil, drugs shown to be trap-
ped in the channel after channel deactivation2, is not altered with an increase
in the extracellular potassium concentration. Furthermore block by both ter-
fenadine and bepridil of the HERG mutant D540K, which opens with both
depolarization and hyperpolarization, is decreased with increased extracellu-
lar potassium, similar to the effect of extracellular potassium on block of WT
HERG by quinidine. In addition, the decrease in block of D540K by bepridil
is less with an increase in extracellular cesium compared to an increase in
extracellular potassium (PCs/PK ¼ 0.33). Finally, preliminary data indicate
that block by bepridil of a number of HERG inactivation deficient mutants
does not depend on extracellular potassium. Together these results suggest
that the permeant ion is not able to destabilize a trapped drug but is able
to destabilize a drug that is not trapped and suggest a possible role for the
activation gate in determining the extracellular potassium dependency of
block of HERG.
1Barrows et al. (2009) Channels: 3(4) :239-248.
2 Stork et al. (2007) BJP151:1368-1376.
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Malfunction of hERG Kþ channels, due to inherited mutations or inhibition
by drugs can cause long QT syndrome, which may lead to life-threatening ar-
rhythmias. A 3-dimensional hERG structure is a prerequisite to understand the
molecular basis of hERG malfunction. To achieve a consensus model we have
carried out an extensive analysis of hERG models, based on different align-
ments of helix S5. The consensus model was validated using a combination
of geometry/packing/normality validation, as well as molecular dynamics sim-
ulations and molecular docking. The model is confirmed by a recent mutation
scanning experiment.1 Subsequently, the refined model was used to study the
conformational flexibility of the hERG pore domain. Extensive molecular dy-
namics simulations revealed that the aromatic side-chains, lining the inner
cavity can adopt a wide variety of conformations. Detailed knowledge of
the hERG channel plasticity will be crucial to help interpreting differences
in channel block of different drugs, since many drugs selectively block certain
channel states.
1 Ju, P., Pages, G., Riek, R. P., Chen, P.C., Torres, A. M., Bansal, P. S.,
Kuyucak, S., Kuchel P. W, Vandenberg, J.I. (2009) J. Biol. Chem. 284,
1000-1008.
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KCNQ1 a-subunits are composed out of six transmembrane segments (S1-S6)
that tetramerize into a functional channel. In vivo, KCNQ1 a-subunits associ-
ate with the b-subunit KCNE1 to generate the slowly activating cardiac IKs
and consequently mutations in KCNQ1 are linked to the congenital LQT1
syndrome. Similar to other Kv channels, the S1-S4 segments form the voltage
sensing domain that senses the membrane potential and that controls the
